𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tomorrow's Cancer Treatments Today: The First 50 Years of the Cancer and Leukemia Group B

✍ Scribed by Mark R. Green; Stephen L. George; Richard L. Schilsky

Book ID
114474185
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
190 KB
Volume
35
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Overview of bladder cancer trials in the
Overview of bladder cancer trials in the Cancer and Leukemia Group B
✍ Eric J. Small; Susan Halabi; Guido Dalbagni; Raj Pruthi; George Phillips; Martin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 1 views

The Cancer and Leukemia Group B (CALGB) Genitourinary Committee has developed a broad range of clinical trials across most stages of bladder cancer. Recurrence rates of superficial bladder cancer after transurethral resection range from 50-70%. Although adjuvant bacillus Calmette-Guerin reduces the